There are now around 600 foreign-owned R&D centers in China, up from about 400 in 2002. The centers are concentrated primarily in the southern and eastern coastal region, which receives 88 percent of China’s foreign direct investment. Last year, Roche, Nokia, Siemens, Ericsson, and Novo Nordisk all established new Chinese R&D outposts. One reason for China’s appeal: it’s second only to the United States in its number of researchers, and Chinese PhDs work for substantially less than their U.S. counterparts.
This startup wants to copy you into an embryo for organ harvesting
With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.
This artist is dominating AI-generated art. And he’s not happy about it.
Greg Rutkowski is a more popular prompt than Picasso.
VR is as good as psychedelics at helping people reach transcendence
On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.
This nanoparticle could be the key to a universal covid vaccine
Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.